Skip to main navigation

albireo_logo_nav.svg

  • About
    • Overview
    • Enterprise Team
    • Board of Directors
    • Partnering
    • Contact
  • Programs & Science
    • Bile Acids and IBAT Inhibition
    • Pipeline
    • Odevixibat
    • A3384
    • Elobixibat
  • Patients & Families
    • Progressive Familial Intrahepatic Cholestasis (PFIC)
    • ALAGILLE SYNDROME
    • BILIARY ATRESIA
    • Chronic (Idiopathic) Constipation
    • ADULT LIVER DISEASES
    • Bile Acid Malabsorption (BAM)
    • Clinical Trials
    • Expanded Use
  • Media & Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Publications
    • 2020 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • Careers
    • Current Openings

10-K

Financials menu

  • Financials & Filings

Stock Information menu

  • Stock Information

governance menu

  • Corporate Governance

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 6, 2019
Document Date
Dec 31, 2018
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Albireo
Issuer
Albireo Pharma, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - EX-101.INS
EX-101.SCH - EX-101.SCH
EX-101.CAL - EX-101.CAL
EX-101.DEF - EX-101.DEF
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE

Shareholder Tools

  • Email Alerts

    Email Alerts

  • RSS

    RSS

  • Print

    Print

 
albireo-white

© 2018 Albireo Pharma, Inc.

Contact |  Terms of Use  |  Privacy Policy      twitter